Q-MT, AC-CT Effective Second-Line Therapy Options For Patients With Nitroimidazole-Refractory Giardiasis, Researchers Say

July 28, 2021

Infectious Disease Advisor (7/27, Lee) reports that in a study published in the Journal of Clinical Infectious Diseases, researchers “found quinacrine monotherapy (Q-MT) and albendazole plus chloroquine combination therapy (AC-CT) to be second-line treatm...